Arcturus Therapeutics Ltd. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows, 21 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-02-07: Reporting owner Payne Joseph E; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-02-07: Reporting owner Kummerfeld Keith C; Form 4; Security Incentive Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-02-07: Reporting owner Chivukula Pad; Form 4; Security Incentive Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-02-07: Reporting owner Chivukula Pad; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-02-07 | Payne Joseph E Officer (President and CEO), 10% Owner | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $4.99 | 2019-02-11 | |
| 2019-02-07 | Kummerfeld Keith C Officer (Vice President of Finance) | 4 | Incentive Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $4.99 | 2019-02-11 | |
| 2019-02-07 | Chivukula Pad Officer (Chief Scientific Officer & COO) | 4 | Incentive Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,667 1,667 owned after | $4.99 | 2019-02-11 | |
| 2019-02-07 | Chivukula Pad Officer (Chief Scientific Officer & COO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,333 38,333 owned after | $4.99 | 2019-02-11 | |
| 2019-01-02 holding as of filing | Kummerfeld Keith C Officer (Vice President of Finance) | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $9.04 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Chivukula Pad Officer (Chief Scientific Officer & COO) | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Payne Joseph E Director, Officer (President and CEO), 10% Owner | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Marquet Magda Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Marquet Magda Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Marquet Magda Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | SASSINE ANDY Director, Officer (Chief Financial Officer) | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | SASSINE ANDY Director, Officer (Chief Financial Officer) | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | SASSINE ANDY Director, Officer (Chief Financial Officer) | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | SASSINE ANDY Director, Officer (Chief Financial Officer) | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | SASSINE ANDY Director, Officer (Chief Financial Officer) | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $4.53 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | BARLOW JAMES F Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | BARLOW JAMES F Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | BARLOW JAMES F Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | FARRELL PETER C Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | FARRELL PETER C Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | FARRELL PETER C Director | 3 | STOCK OPTION (right to purchase) Derivative · Direct | Holding | $8.00 exercise price | 2019-01-02 |